Case isolation and contact tracing can prevent the spread of smallpox

American Journal of Epidemiology

Volumn 158, Issue 2, 2003, Pages 118-128

  Eichner, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bioterrorism; Computer simulation; Contact tracing; Models, theoretical; Patient isolation; Population surveillance; Quarantine; Smallpox

Indexed keywords

SMALLPOX VACCINE;

DISEASE SPREAD;

ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; GENETIC ENGINEERING; HEALTH STATISTICS; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PATIENT CARE; POPULATION RESEARCH; PROGNOSIS; SMALLPOX; SMALLPOX VIRUS; STOCHASTIC MODEL; VACCINATION; VIRUS TRANSMISSION;

BIOLOGICAL WARFARE; COMPUTER SIMULATION; CONTACT TRACING; DISEASE OUTBREAKS; HUMANS; MODELS, STATISTICAL; PATIENT ISOLATION; POPULATION SURVEILLANCE; SMALLPOX; VACCINATION; VARIOLA VIRUS;

EID: 0038156484     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg104     Document Type: Article

References (39)

1. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva, Switzerland: World Health Organization, 1988. (ISBN 92 4 156110 6) (http://www.who.int/emc/diseases/smallpox/Smallpoxeradication.html).
2. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281: 2127-37.
3. O'Toole T. Smallpox: an attack scenario. Emerg Infect Dis 1999;5:540-6.
4. O'Toole T, Mair M, Inglesby TV. Shining light on "Dark Winter." Clin Infect Dis 2002;34:972-83.
5. Bicknell WJ. The case for voluntary smallpox vaccination. N Engl J Med 2002;346:1323-5.
6. Müller J, Kretzschmar M, Dietz K. Contact tracing in stochastic and deterministic epidemic models. Math Biosci 2000;164:39-64.
7. Hanna W. Studies in small-pox and vaccination. Bristol, United Kingdom: John Wright and Sons, Ltd, 1913.
8. Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res 1993;2:23-41.
9. 0 and a recipe for its calculation. Acta Biotheor 2002;50:189-204.
10. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, United Kingdom: Oxford University Press, 1991.
11. Dietz K, Heesterbeek JAP. Bernoulli was ahead of modern epidemiology. Nature 2000;408:513-14.
12. Dietz K, Heesterbeek JA. Daniel Bernoulli's epidemiological model revisited. Math Biosci 2002;180:1-21.
13. Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature 2001;414:748-51.
14. Gani R, Leach S. Correction: transmission potential of smallpox in contemporary populations. Nature 2002;415:1056.
15. Eichner M, Dietz K. Transmission potential of smallpox: estimates based on detailed data from an outbreak. Am J Epidemiol 2003;158:110-17.
16. Jacobs A. Immunity conferred by smallpox vaccine. How long does immunity last? (Letter). BMJ 2002;324:1157.
17. Beeching NJ. Author's reply to "Immunity conferred by smallpox vaccine. How long does immunity last?" (Letter). BMJ 2002;324:1157.
18. Meltzer MI, Damon I, LeDuc JW, et al. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis 2001;7:959-69. (http://www.cdc.gov/ncidod/eid/vol7no6/ meltzer.htm).
19. Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A 2002;99:10935-40.
20. Halloran ME, Longini IM, Nizam A, et al. Containing bioterrorist smallpox. Science 2002;298:1428-32.
21. Epstein JM, Cummings DAT, Chakravarty S, et al. Toward a containment strategy for smallpox bioterror: an individual-based computational approach. Center on Social and Economic Dynamics Working Paper no. 31. Washington, DC: Brookings Institution, 2002. (http://www.brook.edu/dybdocroot/es/ dynamics/papers/bioterrorism.pdf).
22. Bozzette SA, Boer R, Bhatnagar V, et al. A model for a smallpox vaccination policy. N Engl J Med 2003;348:416-25.
23. Bozzette SA, Boer R, Bhatnagar V, et al. Supplementary appendix 1. Rand smallpox-vaccination policy model - model details, assumptions, and detailed results. Waltham, MA: Massachusetts Medical Society, 2003. (http://content.nejm.org/cgi/data/NEJMsa025075/DC1/1).
24. Centers for Disease Control and Prevention. Smallpox: surveillance and investigation. Atlanta, GA: Centers for Disease Control and Prevention, 2002. (http://www.bt.cdc.gov/agent/ smallpox/surveillance/index.asp).
25. Centers for Disease Control and Prevention. Smallpox questions and answers: the disease and the vaccine. Atlanta, GA: Centers for Disease Control and Prevention, 2002. (http:// www.bt.cdc.gov/DocumentsApp/FAQSmallpox.asp?link=2).
26. El-Ad B, Roth Y, Winder A, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 1992;161:446-8.
27. Cohen J. Bioterrorism. Smallpox vaccinations: how much protection remains? Science 2001;294:985.
28. Frelinger JA, Garba ML. Responses to smallpox vaccine. N Engl J Med 2002;347:689-90.
29. Demkowicz WE, Littaua RA, Wang J, et al. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol 1996;70:2627-31.
30. + cytotoxic T lymphocytes and interferon-γ producing T cells after smallpox vaccination. J Infect Dis 2002;185: 1657-9.
31. Mack T. A different view of smallpox and vaccination. N Engl J Med 2003;348:460-3.
32. Dixon CW. Smallpox. London, England: J & A Churchill, Ltd, 1962.
33. Enserink M. How devastating would a smallpox attack really be? Science 2002;296:1592-4.
34. Duncan SR, Scott S, Duncan CJ. Modelling the different smallpox epidemics in England. Philos Trans R Soc Lond B Biol Sci 1994;346:407-19.
35. Dietz K. The incidence of infectious disease under the influence of seasonal fluctuations. In: Berger J, Buhler W, Repges R, et al, eds. Lecture notes in biomathematics. Heidelberg, Germany: Springer Verlag, 1976:1-15.
36. Sander LM, Warren CP, Sokolov IM, et al. Percolation on heterogeneous networks as a model for epidemics. Math Biosci 2002;180:293-305.
37. Barbera J, Macintyre A, Gostin L, et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. JAMA 2001;286:2711-17.
38. Kemper AR, Davis MM, Freed GL. Expected adverse events in a mass smallpox vaccination campaign. Eff Clin Pract 2002;5: 89-99.
39. Glass TA, Schoch-Spana M. Bioterrorism and the people: how to vaccinate a city against panic. Clin Infect Dis 2002;34:217-23.